FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 259

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
MGX Nasdaq Metagenomi Therapeutics, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MNOV Nasdaq MediciNova, Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MRK New York Merck & Co., Inc. 2830
MRKR Nasdaq Marker Therapeutics, Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
NAGE Nasdaq Niagen Bioscience, Inc. 2830
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2830
NATR Nasdaq Natures Sunshine Products, Inc. 2830
NCNA Nasdaq NuCana plc 2830
NEOG Nasdaq Neogen Corporation 2830
NEUP Nasdaq Neuphoria Therapeutics Inc. 2830
NRXP Nasdaq NRx Pharmaceuticals, Inc. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2830
NUVB New York Nuvation Bio Inc. 2830
NVCT Nasdaq Nuvectis Pharma, Inc. 2830
NXTC Nasdaq NextCure, Inc. 2830
OGN New York Organon & Co. 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2830
OMER Nasdaq Omeros Corporation 2830
ONCO Nasdaq Onconetix, Inc. 2830
ORIC Nasdaq ORIC Pharmaceuticals, Inc. 2830
ORINY Over the counter Orion Oyj 2830
OVID Nasdaq Ovid Therapeutics Inc. 2830
PAHC Nasdaq Phibro Animal Health Corporation 2830
PCRX Nasdaq Pacira BioSciences, Inc. 2830
PCSA Nasdaq Processa Pharmaceuticals, Inc. 2830
PHIO Nasdaq Phio Pharmaceuticals Corp. 2830
PHVS Nasdaq Pharvaris N.V. 2830
PMVP Nasdaq PMV Pharmaceuticals, Inc. 2830
PRFX Nasdaq PRF Technologies Ltd. 2830
PRQR Nasdaq ProQR Therapeutics N.V. 2830
PTCT Nasdaq PTC Therapeutics, Inc. 2830
PULM Nasdaq Pulmatrix, Inc. 2830
PYPD Nasdaq PolyPid Ltd. 2830
QCLS Nasdaq Q/C Technologies, Inc. 2830
QTRX Nasdaq Quanterix Corporation 2830
RANI Nasdaq Rani Therapeutics Holdings, Inc. 2830
RAPP Nasdaq Rapport Therapeutics, Inc. 2830
RDHL Nasdaq RedHill Biopharma Ltd. 2830
RDY New York Dr. Reddys Laboratories Limited 2830
RFL New York Rafael Holdings, Inc. 2830
RHHBY Over the counter Roche Holding AG 2830
RIGL Nasdaq Rigel Pharmaceuticals, Inc. 2830
RLMD Nasdaq Relmada Therapeutics, Inc. 2830
RNAZ Nasdaq TransCode Therapeutics, Inc. 2830
Results 150 through 200 of 259